International Journal of Antimicrobial Agents
Volume 36, Issue 4 , Pages 369-373 , October 2010

Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance—antibiotic DU90% profiles with bacterial resistance rates: a visual presentation

  • Suzana Mimica Matanovic

      Affiliations

    • University Hospital Centre Osijek, Huttlerova 4, 31000 Osijek, Croatia
    • Corresponding Author InformationCorresponding author. Tel.: +385 98 640 756; fax: +385 31 512 221.
    • ,
  • Ulf Bergman

      Affiliations

    • Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Pharmacology, and Centre for Pharmacoepidemiology, Karolinska University Hospital–Huddinge, SE-141 86 Stockholm, Sweden
    • ,
  • Dubravka Vukovic

      Affiliations

    • Institute of Public Health of Osijek-Baranja County, Franje Krezme 1, 31000 Osijek, Croatia
    • ,
  • Björn Wettermark

      Affiliations

    • Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Pharmacology, and Centre for Pharmacoepidemiology, Karolinska University Hospital–Huddinge, SE-141 86 Stockholm, Sweden
    • ,
  • Vera Vlahovic-Palcevski

      Affiliations

    • University Hospital Centre Rijeka, Kresimirova 42, 51000 Rijeka, Croatia

Received 15 February 2010 ,Accepted 27 May 2010.

References 

  1. Gould IM. Antimicrobials: an endangered species?. Int J Antimicrob Agents. 2007;30:383–384
  2. Vlahovic-Palcevski V, Francetic I, Palcevski G, Novak S, Abram M, Bergman U. Antimicrobial use at a university hospital: appropriate or misused? A qualitative study. Int J Clin Pharmacol Ther. 2007;45:169–174
  3. Monnet DL, López-Lozano JM. Relationship between antibiotic consumption and resistance in European hospitals. Med Mal Infect. 2005;35(Suppl. 2):S127–S128
  4. Vlahovic-Palcevski V, Morovic M, Palcevski G. Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J Clin Pharmacol. 2000;56:97–101
  5. Goryachkina K, Babak S, Burbello A, Wettemark B, Bergman U. Quality use of medicines: a new method of combining antibiotic consumption and sensitivity data—application in a Russian hospital. Pharmacoepidemiol Drug Saf. 2008;17:636–644
  6. Croatian Agency for Medicinal Products and Medical Devices. http://www.almp.hr/?ln=hr&w=publikacije&d=promet_lijekova_2006 [accessed 24 October 2009].
  7. Croatian Academy of Medical Sciences, Committee for Antibiotic Resistance Surveillance in Croatia. Antibiotic resistance in Croatia, 2006. Zagreb, Croatia: Croatian Academy of Medical Sciences; 2007.
  8. WHO Collaborating Centre for Drug Statistics Methodology. Anatomic Therapeutic Chemical (ATC) Classification Index with Defined Daily Doses (DDDs). Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology; 2005.
  9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Ninth informational supplement. Document M2-A9. Wayne, PA: CLSI; 2006.
  10. Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Åberg H, et al. Drug utilization 90%—a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol. 1998;54:113–118
  11. Goossens H, Ferech M, Vander Stichele R, Elseviers M ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579–587
  12. Muller A, Monnet DL, Talon D, Hénon , Bertrand X. Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol. 2006;61:585–591
  13. Vlahović-Palcevski V, Morović M, Palcevski G, Betica-Radić L. Antimicrobial utilization and bacterial resistance at three different hospitals. Eur J Epidemiol. 2001;17:375–383
  14. Leflon-Guibout V, Ternat G, Heym B, Nicolas-Chanoine MH. Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection. J Antimicrob Chemother. 2002;49:367–371
  15. Kahlmeter G  ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother. 2003;51:69–76

PII: S0924-8579(10)00243-8

doi: 10.1016/j.ijantimicag.2010.05.019

International Journal of Antimicrobial Agents
Volume 36, Issue 4 , Pages 369-373 , October 2010

Article Tools

* Image Usage & Resolution